六甲蜜胺

六甲蜜胺 基本信息
CAS号 645-05-6 分子式 C9H18N6
分子量 210.27900 精确质量  210.15900
PSA  48.39000 LogP  0.06960

基本信息 展开↓

CAS号:
645-05-6
3D弹球模型:
立即前往扯扯看
分子式:
C9H18N6
分子量:
210.27900
中文名称:
六甲蜜胺
英文名称:
hexamethylmelamine
中文别名:
六甲蜜胺;
六甲三聚氰胺;
2,4,6-三(二甲氨基)均三嗪;
六甲聚腈胺
英文别名:
hexamethylmelamine;
Altretamine;
Hexalen;
Hexastat;
NC 195;
N,N,N',N',N'',N''-hexamethyl-1,3,5-triazine-2,4,6-triamine;
N2,N2,N4,N4,N6,N6-hexamethyl-1,3,5-triazine-2,4,6-triamine;
HMM;
N,N,N’,N’,N″,N″-hexamethyl-1,3,5-triazine-2,4,6-triamine;
altretamine;
HTM;
Hemel;
2,4,6-tris-1,3,5-triazine;
Hexylen;
hemel
精确分子量/精确质量:
210.15900
极性分子表面积/PSA:
48.39000
油水分配系数/LogP:

LogP值指的是某物质在正辛醇/水两相体系中的分配系数的对数值,反映了物质在油水两相中的分配情况。其中、LogP值越大,说明该物质越亲油;反之,LogP值越小,则说明该物质越亲水。
贝尔斯坦号/MDL:
MFCD00549245
EINECS:
211-428-4
PubChem:
24278242
InChI:
InChI=1/C9H24N6/c1-10(2)13-7-14(11(3)4)9-15(8-13)12(5)6/h7-9H2,1-6H3

生产制备方法及用途展开↓

制备方法


由三氯三聚氰与二甲胺缩合而得

合成制备方法


由三氯三聚氰与二甲胺缩合而得

用途简介


抗肿瘤药物

用途


抗肿瘤药物

物化性质展开↓

外观与性状:
无色结晶固体
密度:
1.148 g/cm3
熔点:
171-175 °C(lit.)
沸点:
301ºC
闪点:
159.1ºC
水溶解性:
Insoluble
折射率:
1.569
存储条件/存储方法:

常温,2-8℃,避光,通风干燥处

稳定性相关:

白色针状结晶。熔点170-173,易溶于

氯仿,微溶于甲醇、乙醇,极微溶于水,对酸碱稳定。具升华性

其它信息:

1.       性状:白色针状结晶

2.       密度(g/mL,25/4):

3.       相对蒸汽密度(g/mL,空气=1):

4.       熔点(ºC):171-175

5.       沸点(ºC,常压):301

6.       沸点(ºC,5.2kPa):未确定

7.       折射率:

8.       闪点(ºC):

9.       比旋光度(º):

10.    自燃点或引燃温度(ºC):

11.    蒸气压(kPa,25ºC):

12.    饱和蒸气压(kPa,60ºC):

13.    燃烧热(KJ/mol):

14.    临界温度(ºC):

15.    临界压力(KPa):

16.    油水(辛醇/水)分配系数的对数值:

17.    爆炸上限(%,V/V):

18.    爆炸下限(%,V/V):

19.    溶解性:不溶于水

安全信息展开↓

海关代码:
2933699090
WGK_Germany:
3
德国有关水污染物质的分类清单
危险类别码:
R22;R36/37/38
安全说明:
S26-S36
RTECS号:
OS1050000
安全标志:
S26:万一接触眼睛,立即使用大量清水冲洗并送医诊治。
S36:穿戴合适的防护服装。
危险标志:
Xn: Harmful;

合成路线查看所有的合成路线

  • 108-77-0

    三氯三聚氰

  • +

  • 124-40-3

    二甲胺

  • ~96%

  • 645-05-6

    六甲蜜胺

  • 103-83-3

    N,N-二甲基苄胺

  • +

  • 108-77-0

    三氯三聚氰

  • ~91%

  • 645-05-6

    六甲蜜胺

  • +

  • 100-44-7

    苄基氯

  • 1467-79-4

    二甲基氢胺

  • ~91%

  • 645-05-6

    六甲蜜胺

毒理性展开↓

CHEMICAL IDENTIFICATION

RTECS NUMBER :
OS1050000
CHEMICAL NAME :
Melamine, hexamethyl-
CAS REGISTRY NUMBER :
645-05-6
BEILSTEIN REFERENCE NO. :
0195058
LAST UPDATED :
199612
DATA ITEMS CITED :
26
MOLECULAR FORMULA :
C9-H18-N6
MOLECULAR WEIGHT :
210.33
WISWESSER LINE NOTATION :
T6N CN ENJ BN1&1 DN1&1 FN1&1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human
DOSE/DURATION :
8 mg/kg
TOXIC EFFECTS :
Gastrointestinal - nausea or vomiting Blood - leukopenia
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
350 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
265 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
437 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - chromodacryorrhea Blood - hemorrhage
TYPE OF TEST :
LD10 - Lethal Dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
200 mg/kg
TOXIC EFFECTS :
Blood - granulocytopenia Blood - changes in bone marrow (not otherwise specified)
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
171 mg/kg
TOXIC EFFECTS :
Cardiac - cardiomyopathy including infarction Liver - hepatitis (hepatocellular necrosis), zonal
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
100 mg/kg
TOXIC EFFECTS :
Blood - pigmented or nucleated red blood cells Blood - changes in leukocyte (WBC) count Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - transaminases
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
255 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Bird - chicken
DOSE/DURATION :
341 mg/kg
TOXIC EFFECTS :
Peripheral Nerve and Sensation - flaccid paralysis without anesthesia (usually neuromuscular blockage) Behavioral - ataxia
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
3080 mg/kg/77D-I
TOXIC EFFECTS :
Gastrointestinal - changes in structure or function of endocrine pancreas Endocrine - hyperglycemia Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
625 mg/kg/5D-I
TOXIC EFFECTS :
Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
625 mg/kg/5D-I
TOXIC EFFECTS :
Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
250 mg/kg/5D-I
TOXIC EFFECTS :
Blood - changes in bone marrow (not otherwise specified) Blood - other changes Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
3108 mg/kg/3Y-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Blood - leukemia
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
7 gm/kg/46W-C
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Kidney, Ureter, Bladder - Kidney tumors Skin and Appendages - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
1240 mg/kg
SEX/DURATION :
male 62 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - testes, epididymis, sperm duct Reproductive - Fertility - male fertility index (e.g. # males impregnating females per # males exposed to fertile nonpregnant females) Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
320 mg/kg
SEX/DURATION :
female 6-9 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
320 mg/kg
SEX/DURATION :
female 9-12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
1160 mg/kg
SEX/DURATION :
female 15-22 day(s) after conception lactating female 21 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive) Reproductive - Effects on Newborn - weaning or lactation index (e.g., # alive at weaning per # alive at day 4)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
80 mg/kg
SEX/DURATION :
female 15-22 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
780 mg/kg
SEX/DURATION :
female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
TYPE OF TEST :
Sex chromosome loss and nondisjunction
TYPE OF TEST :
Cytogenetic analysis

MUTATION DATA

TYPE OF TEST :
DNA damage
TEST SYSTEM :
Mammal - species unspecified Lymphocyte
DOSE/DURATION :
250 umol/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year: 43,500,1983
生态数据:

通常对水是不危害的,若无政府许可,勿将材料排入周围环境

海关数据查看详细

中国海关编码:2933699090

概述:
2933699090 其他结构上含非稠合三嗪环化合物. 增值税率:17.0% 退税率:9.0% 监管条件:无 最惠国关税:6.5% 普通关税:20.0%
申报要素:
品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期
摘要/Summary:
2933699090 other compounds containing an unfused triazine ring (whether or not hydrogenated) in the structure。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:20.0%

分子结构与计算化学数据展开↓

计算化学数据


1.疏水参数计算参考值(XlogP):无

2.氢键供体数量:0

3.氢键受体数量:6

4.可旋转化学键数量:3

5.互变异构体数量:无

6.拓扑分子极性表面积48.4

7.重原子数量:15

8.表面电荷:0

9.复杂度:148

10.同位素原子数量:0

11.确定原子立构中心数量:0

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:1

上下游相关产品

上游产品

更多
  • 1467-79-4

    二甲基氢胺

  • 108-77-0

    三氯三聚氰

  • 124-40-3

    二甲胺

  • 123-39-7

    N-甲基甲酰胺

  • 103-83-3

    N,N-二甲基苄胺

下游产品

更多
  • 124-40-3

    二甲胺

  • 108-80-5

    氰尿酸

立即下载安装“化学加”APP
专业、功能强大,随时调用更加方便